- Home
- MDT vs GSK Comparison
MDT vs GSK Comparison
Compare MDT & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDT | GSK |
|---|---|---|
| Founded | 1949 | 1715 |
| Country | Ireland | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.9B | 95.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MDT | GSK |
|---|---|---|
| Price | $99.72 | $48.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 1 |
| Target Price | ★ $108.63 | N/A |
| AVG Volume (30 Days) | ★ 7.7M | 4.2M |
| Earning Date | 11-18-2025 | 10-29-2025 |
| Dividend Yield | 2.84% | ★ 3.40% |
| EPS Growth | 12.98 | ★ 118.57 |
| EPS | ★ 3.69 | 1.79 |
| Revenue | $34,758,000,000.00 | ★ $43,237,357,842.00 |
| Revenue This Year | $8.60 | $6.56 |
| Revenue Next Year | $5.83 | $5.13 |
| P/E Ratio | ★ $27.06 | $27.33 |
| Revenue Growth | ★ 5.34 | 2.73 |
| 52 Week Low | $79.29 | $31.72 |
| 52 Week High | $106.33 | $49.31 |
Technical Indicators
Market Signals| Indicator | MDT | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 51.68 | 60.04 |
| Support Level | $99.49 | $47.20 |
| Resistance Level | $101.39 | $49.31 |
| Average True Range (ATR) | 1.63 | 0.61 |
| MACD | -0.56 | -0.04 |
| Stochastic Oscillator | 11.81 | 81.02 |
Price Performance
Historical ComparisonAbout MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.